36 devices · GMDN 60780
Troponin I immunoassay kits use chemiluminescent technology to detect cardiac troponin I levels in blood samples, helping diagnose or rule out acute myocardial infarction (heart attack) and assess heart injury severity. Clinicians rely on these tests for rapid, sensitive detection of cardiac troponin I, a biomarker released when heart muscle is damaged.
These devices are typically regulated as in vitro diagnostics (IVDs) and may require performance validation, such as analytical sensitivity and clinical accuracy studies. They are commonly supplied as reagent kits or cartridges for automated or semi-automated analyzers, with some designed for point-of-care or laboratory use.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.